Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

11.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.1K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

7.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.3K
Protein Networks02:26

Protein Networks

4.5K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.5K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.3K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

989
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
989
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

364
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
364

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tuning the electrical transport of type II Weyl semimetal WTe<sub>2</sub> nanodevices by Ga+ ion implantation.

Scientific reports·2017
Same author

Targeting the middle region of CP4-EPSPS protein for its traceability in highly processed soy-related products.

Journal of food science and technology·2017
Same author

qPrimerDB: a thermodynamics-based gene-specific qPCR primer database for 147 organisms.

Nucleic acids research·2017
Same author

Whole-lesion apparent diffusion coefficient histogram analysis: significance in T and N staging of gastric cancers.

BMC cancer·2017
Same author

Advances in thermoelectric materials research: Looking back and moving forward.

Science (New York, N.Y.)·2017
Same author

A Novel Aerobic Degradation Pathway for Thiobencarb Is Initiated by the TmoAB Two-Component Flavin Mononucleotide-Dependent Monooxygenase System in Acidovorax sp. Strain T1.

Applied and environmental microbiology·2017

Related Experiment Video

Updated: Jan 17, 2026

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.1K

An inductive learning-based method for predicting drug-gene interactions using a multi-relational drug-disease-gene

Jian He1, Yanling Wu1, Linxi Yuan1

  • 1College of Chemistry, Sichuan University, Chengdu, 610064, China.

Journal of Pharmaceutical Analysis
|September 22, 2025
PubMed
Summary

This study introduces a novel inductive learning model to accurately identify unseen drug-gene interactions (DGIs). The model effectively predicts new interactions, accelerating drug discovery and repurposing.

Keywords:
Drug-gene interactionsGraph embeddingInductive learningMachine learningMulti-relational drug-disease-gene graphNode attributes

More Related Videos

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.2K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.5K

Related Experiment Videos

Last Updated: Jan 17, 2026

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.1K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.2K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.5K

Area of Science:

  • Computational biology
  • Bioinformatics
  • Machine learning

Background:

  • Drug-gene interactions (DGIs) are crucial for drug discovery.
  • Current transductive learning models struggle with predicting interactions involving entirely new drugs or genes (unseen DGIs).
  • Data sparsity is a challenge in DGI prediction.

Purpose of the Study:

  • To develop an inductive learning-based model for precise identification of unseen drug-gene interactions (DGIs).
  • To improve the prediction of both known and novel DGIs.

Main Methods:

  • Constructed a multi-relational drug-disease-gene (DDG) graph integrating disease nodes to mitigate data sparsity.
  • Extracted graph features using graph embedding algorithms and retrieved individual gene/drug node attributes.
  • Developed a hybrid feature representation by combining graph features and node attributes.
  • Implemented an innovative inductive learning approach by transforming known node vectors into unseen node representations using node similarities as weights.

Main Results:

  • The proposed inductive learning model significantly outperformed existing models in predicting both external unknown and unseen DGIs.
  • The model demonstrated practical feasibility through case studies and molecular docking.
  • Achieved accurate and cost-effective DGI detection.

Conclusions:

  • This study presents an efficient, data-driven approach for DGI prediction using inductive learning.
  • The model offers a promising tool for accelerating drug discovery and repurposing by identifying novel interactions.
  • The integration of disease nodes and hybrid feature characterization enhances prediction accuracy.